We are live on ! Find out more
LP

Longaeva Partners Portfolio holdings

AUM $4.58B
1-Year Est. Return 43.91%
This Fund
S&P 500
This Quarter Est. Return
-3.4%
1 Year Est. Return
+43.91%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.7B
AUM Growth
+$1.51B
Cap. Flow
+$1.41B
Cap. Flow %
52.36%
Top 10 Hldgs %
35.87%
Holding
269
New
150
Increased
33
Reduced
19
Closed
65

Top Buys

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$80.3M
2
BSX icon
Boston Scientific
BSX
+$76.6M
3
KEY icon
KeyCorp
KEY
+$62.3M
4
GS icon
Goldman Sachs
GS
+$60.3M
5
MMED
MiniMed Group Inc
MMED
+$52.4M

Top Sells

Rank Stock Value
1
CAI
Caris Life Sciences
CAI
+$40.7M
2
BDX icon
Becton Dickinson
BDX
+$25.5M
3
TPG icon
TPG
TPG
+$23.9M
4
NVO
Novo Nordisk
NVO
+$22.6M
5
EW icon
Edwards Lifesciences
EW
+$22.1M

Sector Composition

Rank Sector Weight
1 Financials 31.18%
2 Miscellaneous 23.14%
3 Healthcare 16.78%
4 Technology 12.09%
5 Industrials 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FHN icon
76
First Horizon
FHN
$11.7B
$9.09M 0.34%
399,537
+236,201
+145% +$5.65M
PH icon
77
Parker-Hannifin
PH
$125B
$9.04M 0.33%
+10,101
New +$9.56M
DXCM icon
78
DexCom
DXCM
$34.3B
$8.48M 0.31%
+135,000
New +$9.4M
STX icon
79
Seagate
STX
$188B
$8.42M 0.31%
+21,502
New +$8.2M
META icon
80
CALL
Meta Platforms (Facebook)
META
$1.47T
$8.18M 0.3%
+14,300
New +$9.16M
BURL icon
81
Burlington
BURL
$17.1B
$8.11M 0.3%
24,934
+12,413
+99% +$3.8M
HEI icon
82
HEICO Corp
HEI
$47B
$7.82M 0.29%
+28,536
New +$9.19M
IMTX icon
83
Immatics
IMTX
$1.44B
$7.68M 0.28%
780,967
+736,366
+1,651% +$7.22M
MLTX icon
84
MoonLake Immunotherapeutics
MLTX
$1.28B
$7.64M 0.28%
+410,000
New +$6.79M
MAR icon
85
Marriott International
MAR
$91.5B
$7.23M 0.27%
22,100
+8,336
+61% +$2.74M
SSB icon
86
SouthState Bank Corp
SSB
$10.3B
$7.19M 0.27%
77,688
-8,504
-10% -$834K
INSP icon
87
Inspire Medical Systems
INSP
$1.78B
$7.16M 0.27%
+138,761
New +$9.71M
SNPS icon
88
Synopsys
SNPS
$84.8B
$6.98M 0.26%
+17,617
New +$7.96M
SVRA icon
89
Savara
SVRA
$1.08B
$6.96M 0.26%
1,275,000
+28,958
+2% +$161K
FISV
90
Fiserv Inc
FISV
$28.3B
$6.87M 0.25%
+123,042
New +$7.61M
TMDX icon
91
Transmedics
TMDX
$3.07B
$6.86M 0.25%
+69,057
New +$9.01M
AMGN icon
92
Amgen
AMGN
$234B
$6.83M 0.25%
+19,413
New +$6.92M
ORKA
93
Oruka Therapeutics
ORKA
$6.03B
$6.71M 0.25%
136,884
+8,774
+7% +$305K
ASML icon
94
CALL
ASML
ASML
$651B
$6.6M 0.24%
+5,000
New +$6.85M
CNC icon
95
Centene
CNC
$32B
$6.52M 0.24%
199,000
-24,597
-11% -$1.01M
DIOD icon
96
Diodes
DIOD
$4.05B
$6.48M 0.24%
+94,881
New +$5.98M
WH icon
97
Wyndham Hotels & Resorts
WH
$5.64B
$6.47M 0.24%
79,700
+54,700
+219% +$4.29M
CRL icon
98
Charles River Laboratories
CRL
$13.9B
$6.33M 0.23%
+36,721
New +$6.81M
RBC icon
99
RBC Bearings
RBC
$15.8B
$6.24M 0.23%
+11,483
New +$6.1M
SAIA icon
100
Saia
SAIA
$9.37B
$6M 0.22%
+17,089
New +$6.23M
2 3
4
5 6

Similar funds

CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
MR
Munich Reinsurance Munich $4.57B AUM 28.39% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.59B AUM 9.32% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
AF
Avanza Fonder Stockholm, Sweden $4.59B AUM 41.03% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM

Longaeva Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Longaeva Partners held 269 positions worth $2.7B, up 127% from $1.19B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Longaeva Partners deployed $1.41B of net new capital in Q1 2026, opening 150 new positions and adding to 33 existing holdings. Its largest new stake was Bank of America: 1,555,661 shares worth $75.8M.

By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 22% a quarter earlier, followed by Miscellaneous and Healthcare.

On the sell side, the largest reduction was Annexon, an estimated $14M trimmed.

  • Longaeva Partners's largest Q1 2026 buy was Bank of America: 1,555,661 shares worth $75.8M.
  • Longaeva Partners added most to PNC Financial Services in Q1 2026, an estimated $48M increase.
  • Longaeva Partners's biggest Q1 2026 reduction was Annexon, cutting an estimated $14M.
  • Longaeva Partners fully exited Caris Life Sciences in Q1 2026, selling an estimated $40.7M.
  • Longaeva Partners's ten largest holdings make up 36% of its $2.7B portfolio in Q1 2026.
  • Longaeva Partners opened 150 new positions and closed 65 in Q1 2026.
  • Longaeva Partners's portfolio value rose 127% quarter-over-quarter to $2.7B.

Based on Longaeva Partners's 13F filing for Q1 2026, filed 15 May 2026.